Mangalam Drugs and Organics Ltd. | Small-cap | Healthcare
₹80.31
1.44%
| Mangalam Drugs Stock Comparison:
No comparison data available
Overview Income Statement Balance Sheet Cash Flow Key Ratios

Financial Overview

Latest Annual: 2025

Income Metrics

Revenue 3.2B
Gross Profit 1.5B 47.30%
Operating Income 192.2M 6.05%
Net Income 67.2M 2.12%
EPS (Diluted) ₹4.25

Balance Sheet Metrics

Total Assets 3.7B
Total Liabilities 2.2B
Shareholders Equity 1.5B
Debt to Equity 1.46

Cash Flow Metrics

Operating Cash Flow 24.3M
Free Cash Flow 223.9M

Revenue & Profitability Trend

Mangalam Drugs Income Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Revenue 3.2B 3.7B 0 4.5B 3.8B
Cost of Goods Sold 1.7B 2.9B 0 3.5B 2.8B
Gross Profit 1.5B 706.7M 0 987.4M 976.7M
Operating Expenses 744.5M 164.5M 153.4M 731.9M 135.9M
Operating Income 192.2M 10.5M 0 387.6M 444.5M
Pre-tax Income 47.9M -110.7M 0 277.3M 395.2M
Income Tax -19.3M -20.0M 0 80.8M 115.5M
Net Income 67.2M -90.7M 0 196.6M 279.7M
EPS (Diluted) ₹4.25 -₹5.73 ₹0.00 ₹12.42 ₹17.67

Income Statement Trend

Mangalam Drugs Balance Sheet From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Assets
Current Assets 2.0B 1.8B 2.1B 1.9B 1.3B
Non-Current Assets 1.7B 1.6B 1.5B 1.4B 1.3B
Total Assets 3.7B 3.3B 3.6B 3.3B 2.6B
Liabilities
Current Liabilities 1.9B 1.6B 1.7B 1.3B 1.1B
Non-Current Liabilities 258.4M 338.5M 423.2M 477.5M 242.5M
Total Liabilities 2.2B 2.0B 2.1B 1.8B 1.3B
Equity
Total Shareholders Equity 1.5B 1.4B 1.5B 1.5B 1.3B

Balance Sheet Composition

Mangalam Drugs Cash Flow Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Operating Activities
Net Income 47.9M 39.7M 22.1M 277.3M 395.2M
Operating Cash Flow 24.3M 159.8M -30.1M 92.9M 432.4M
Investing Activities
Capital Expenditures -194.7M -118.3M -221.7M -275.3M -312.9M
Investing Cash Flow -194.7M -118.3M -221.7M -275.3M -312.9M
Financing Activities
Dividends Paid - - - - -
Financing Cash Flow -26.6M 169.4M 24.7M -40.9M 93.2M
Free Cash Flow 223.9M -79.2M 116.1M -19.6M -38.9M

Cash Flow Trend

Mangalam Drugs Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 18.94
Price to Book 0.80
Price to Sales 0.40
PEG Ratio -0.11

Profitability Ratios

Profit Margin 2.12%
Operating Margin 7.49%
Return on Equity 4.72%
Return on Assets 3.43%

Financial Health

Current Ratio 1.04
Debt to Equity 64.59
Beta -0.06

Per Share Data

EPS (TTM) ₹4.25
Book Value per Share ₹100.32
Revenue per Share ₹200.83

Financial data is updated regularly. All figures are in the company's reporting currency.